본문으로 건너뛰기
← 뒤로

Clinical significance of cachexia index determined by bioelectrical impedance analysis in patients with gastrointestinal cancer.

1/5 보강
Oncology letters 📖 저널 OA 100% 2022: 2/2 OA 2023: 13/13 OA 2024: 15/15 OA 2025: 100/100 OA 2026: 132/132 OA 2022~2026 2025 Vol.29(3) p. 114
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
54 patients with gastrointestinal cancer undergoing BIA at the time of diagnosis at Fukuchiyama City Hospital (Kyoto, Japan) were retrospectively recruited.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
By contrast, the SMI had no significant effect on OS. Thus, CXI values using BIA may predict survival in patients with gastrointestinal cancer.

Ohara T, Iwai N, Oka K, Okabe K, Sakai H, Tsuji T

📝 환자 설명용 한 줄

Cancer cachexia is a complex disorder characterized by skeletal muscle loss, which may influence the prognosis of patients with cancer.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P=0.012

이 논문을 인용하기

↓ .bib ↓ .ris
APA Ohara T, Iwai N, et al. (2025). Clinical significance of cachexia index determined by bioelectrical impedance analysis in patients with gastrointestinal cancer.. Oncology letters, 29(3), 114. https://doi.org/10.3892/ol.2024.14860
MLA Ohara T, et al.. "Clinical significance of cachexia index determined by bioelectrical impedance analysis in patients with gastrointestinal cancer.." Oncology letters, vol. 29, no. 3, 2025, pp. 114.
PMID 39802313 ↗

Abstract

Cancer cachexia is a complex disorder characterized by skeletal muscle loss, which may influence the prognosis of patients with cancer. The cachexia index (CXI) is a new index for cachexia. The present study aimed to assess whether the CXI determined by bioelectrical impedance analysis (BIA) is valuable for predicting survival in patients with gastrointestinal cancer. A total of 54 patients with gastrointestinal cancer undergoing BIA at the time of diagnosis at Fukuchiyama City Hospital (Kyoto, Japan) were retrospectively recruited. CXI values were calculated as follows: CXI=skeletal muscle index (SMI) × serum albumin concentration/neutrophil-to-lymphocyte ratio. The SMI was measured using BIA values. The patients were classified into low- and high-CXI groups. The median patient age was 72 years and 63.0% of patients were male. A total of 20 patients with colorectal cancer were enrolled, 12 with pancreatic cancer, 11 with gastric cancer, 6 with esophageal cancer, 4 with biliary tract cancer and 1 with liver cancer. The cumulative one-year overall survival (OS) rate was significantly worse in the low-CXI group compared with that in the high-CXI group (58.3 vs. 88.5%; P=0.012). By contrast, the SMI had no significant effect on OS. Thus, CXI values using BIA may predict survival in patients with gastrointestinal cancer.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기